Show simple item record

Endothelial barrier dysfunction caused by LPS correlates with phosphorylation of HSP27 in vivo

dc.contributor.authorHirano, S.en_US
dc.contributor.authorRees, Riley S.en_US
dc.contributor.authorYancy, S. L.en_US
dc.contributor.authorWelsh, Michael J.en_US
dc.contributor.authorRemick, Daniel G.en_US
dc.contributor.authorYamada, Tadatakaen_US
dc.contributor.authorHata, J.en_US
dc.contributor.authorGilmont, Robert R.en_US
dc.date.accessioned2006-09-08T20:27:43Z
dc.date.available2006-09-08T20:27:43Z
dc.date.issued2004-01en_US
dc.identifier.citationHirano, S.; Rees, R.S.; Yancy, S.L.; Welsh, M.J.; Remick, D.G.; Yamada, T.; Hata, J.; Gilmont, R.R.; (2004). "Endothelial barrier dysfunction caused by LPS correlates with phosphorylation of HSP27 in vivo ." Cell Biology and Toxicology 20(1): 1-14. <http://hdl.handle.net/2027.42/42550>en_US
dc.identifier.issn0742-2091en_US
dc.identifier.issn1573-6822en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/42550
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=15119843&dopt=citationen_US
dc.description.abstractLung edema during sepsis is triggered by formation of gaps between endothelial cells followed by macrophage infiltration. Endothelial gap formation has been proposed to involve changes in the structure of the actin filament cytoskeleton. Heat shock protein 27 (HSP27) is believed to modulate actin filament dynamics or structure, in a manner dependent on its phosphorylation status. We hypothesized that HSP27 may play a role in endothelial gap formation, by affecting actin dependent events in endothelial cells. As there has been no report concerning HSP27 in lung edema in vivo , we examined induction and phosphorylation of HSP27 in lung following LPS injection, as a model of sepsis. In lung, HSP27 mainly localized in capillary endothelial cells of the alveolus, and in smooth muscle cells of pulmonary arteries. HSP27 became significantly more phosphorylated at 3 h after LPS treatment, while the distribution of HSP27 remained unchanged. Pre-treatment with anti-TNFα antibody, which has been shown to reduce lung injury, blocked increases in HSP27 phosphorylation at 3 h. HSP27 phosphorylation was also increased in cultured rat pulmonary arterial endothelial cells (RPAEC) by treatment with TNFα, LPS, or H 2 O 2 . This phosphorylation was blocked by pre-treatment with SB203580, an inhibitor of the upstream kinase, p38 MAP kinase. Increased endothelial permeability caused by H 2 O 2 in vitro was also blocked by SB203580. The amount of actin associated with HSP27 was reduced after treatment with LPS, or H 2 O 2 . In summary, HSP27 phosphorylation temporally correlated with LPS induced pathological endothelial cell gap formation in vivo and in a cell culture model system. This is the first report of increased HSP27 phosphorylation associated with pathological lung injury in an animal model of sepsis.en_US
dc.format.extent593567 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherKluwer Academic Publishers; Springer Science+Business Mediaen_US
dc.subject.otherLife Sciencesen_US
dc.subject.otherPharmacology/Toxicologyen_US
dc.subject.otherBiochemistry, Generalen_US
dc.subject.otherCell Biologyen_US
dc.subject.otherEndothelial Cellsen_US
dc.subject.otherHearten_US
dc.subject.otherHydrogen Peroxideen_US
dc.subject.otherLPSen_US
dc.subject.otherLung Injuryen_US
dc.subject.otherTNFαen_US
dc.titleEndothelial barrier dysfunction caused by LPS correlates with phosphorylation of HSP27 in vivoen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPublic Healthen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Surgery, University of Michigan Medical Center, Ann Arbor, MI, USA; Cell and Developmental Biology, University of Michigan Medical Center, Ann Arbor, MI, USAen_US
dc.contributor.affiliationumDepartment of Surgery, University of Michigan Medical Center, Ann Arbor, MI, USAen_US
dc.contributor.affiliationumCell and Developmental Biology, University of Michigan Medical Center, Ann Arbor, MI, USAen_US
dc.contributor.affiliationumCell and Developmental Biology, University of Michigan Medical Center, Ann Arbor, MI, USAen_US
dc.contributor.affiliationumPathology, University of Michigan Medical Center, Ann Arbor, MI, USAen_US
dc.contributor.affiliationumDepartment of Surgery, University of Michigan Medical Center, Ann Arbor, MI, USAen_US
dc.contributor.affiliationotherDepartment of Pathology, Keio University, School of Medicine, Tokyo, Japanen_US
dc.contributor.affiliationotherDepartment of Pathology, Keio University, School of Medicine, Tokyo, Japanen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid15119843en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/42550/1/10565_2004_Article_5256090.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1023/B:CBTO.0000021019.50889.aaen_US
dc.identifier.sourceCell Biology and Toxicologyen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.